These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7142519)

  • 1. Immunohistological localization of three basement membrane components in various forms of epidermolysis bullosa.
    Kero M; Peltonen L; Foidart JM; Savolainen ER
    J Cutan Pathol; 1982 Oct; 9(5):316-28. PubMed ID: 7142519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.
    Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K
    J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.
    Kennedy AR; Heagerty AH; Ortonne JP; Hsi BL; Yeh CJ; Eady RA
    Br J Dermatol; 1985 Dec; 113(6):651-9. PubMed ID: 3913455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa.
    Fine JD; Horiguchi Y; Couchman JR
    Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis.
    Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA
    Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nidogen and heparan sulfate proteoglycan: detection of newly isolated basement membrane components in normal and epidermolysis bullosa skin.
    Caughman SW; Krieg T; Timpl R; Hintner H; Katz SI
    J Invest Dermatol; 1987 Dec; 89(6):547-50. PubMed ID: 2960746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of major variants of congenital epidermolysis bullosa using a monoclonal antibody against collagen type IV.
    Bolte C; Gonzalez S
    Am J Dermatopathol; 1995 Dec; 17(6):580-3. PubMed ID: 8599472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a functional defect of the lamina lucida in recessive dystrophic epidermolysis bullosa demonstrated by suction blisters.
    Tidman MJ; Eady RA
    Br J Dermatol; 1984 Oct; 111(4):379-87. PubMed ID: 6487542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa.
    Petronius D; Bergman R; Ben Izhak O; Leiba R; Sprecher E
    Am J Dermatopathol; 2003 Jun; 25(3):198-203. PubMed ID: 12775981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa.
    Rao R; Mellerio J; Bhogal BS; Groves R
    Indian J Dermatol Venereol Leprol; 2012; 78(6):692-7. PubMed ID: 23075637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural findings in epidermolysis bullosa.
    Smith LT
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunofluorescence mapping for diagnosis of congenital epidermolysis bullosa].
    Cepeda-Valdés R; Pohla-Gubo G; Borbolla-Escoboza JR; Barboza-Quintana O; Ancer-Rodríguez J; Hintner H; Salas-Alanis JC
    Actas Dermosifiliogr; 2010 Oct; 101(8):673-82. PubMed ID: 20965010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructure and molecular pathogenesis of epidermolysis bullosa.
    Shinkuma S; McMillan JR; Shimizu H
    Clin Dermatol; 2011; 29(4):412-9. PubMed ID: 21679868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa.
    Fine JD; Breathnach SM; Hintner H; Katz SI
    J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin 6-sulfate proteoglycan but not heparan sulfate proteoglycan is abnormally expressed in skin basement membrane from patients with dominant and recessive dystrophic epidermolysis bullosa.
    Fine JD; Couchman JR
    J Invest Dermatol; 1989 Apr; 92(4):611-6. PubMed ID: 2522973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermolysis bullosa].
    García Pérez A
    An R Acad Nac Med (Madr); 1999; 116(2):387-413; discussion 413-5. PubMed ID: 10682398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolysis bullosa: a review.
    Cooper TW; Bauer EA
    Pediatr Dermatol; 1984 Jan; 1(3):181-8. PubMed ID: 6387664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of 19-DEJ-1 monoclonal antibody for the prenatal diagnosis or exclusion of junctional epidermolysis bullosa.
    Fine JD; Holbrook KA; Elias S; Anton-Lamprecht I; Rauskolb R
    Prenat Diagn; 1990 Apr; 10(4):219-29. PubMed ID: 2195497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.